← Back to Search

Live Donor Advocacy Training + Social Media for Kidney Failure (ENGAGE Trial)

N/A

Waitlist Available

Led By Andrew Cameron, MD PhD

Research Sponsored by Johns Hopkins University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Participants at Northwestern University must speak English or Spanish.

Kidney transplant candidates aged≥18 added to the waitlist in the last year with no potential live donors are eligible.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within 6 months of enrollment

Awards & highlights

ENGAGE Trial Summary

This trial will test a new educational intervention and mobile health intervention for people with end stage renal disease who don't have a potential live donor yet.

Who is the study for?

This trial is for adults over 18 with end-stage renal disease (ESRD) who've been on the kidney transplant waitlist in the past year without a live donor. It's open to English speakers at Johns Hopkins and University of Alabama, and English or Spanish speakers at Northwestern University.Check my eligibility

What is being tested?

The study tests an educational program plus a Facebook app versus just the app to see if they help ESRD patients find kidney donors. The goal is to check how well these methods work in helping patients get live donors.See study design

What are the potential side effects?

Since this trial involves education and use of social media rather than medical treatments, there are no direct medical side effects. However, participants may experience emotional or psychological impacts from engaging with social media.

ENGAGE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I speak English or Spanish.

Select...

I am over 18, need a kidney transplant, and have no live donors.

ENGAGE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 6 months of enrollment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 6 months of enrollment

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 6 months of enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Live donor kidney transplantation

Secondary outcome measures

Live Donor Inquiries

comfort initiating conversations

knowledge of live donation

ENGAGE Trial Design

3Treatment groups

Active Control

Group I: Standard of CareActive Control1 Intervention

Standard of Care does not include any of the interventions detailed above, but rather normal routine care as this is the control group.

Group II: Live Donor Champion + Facebook AppActive Control1 Intervention

The LDC program consists of 6 monthly sessions of approx. 1 hour each. Each LDC session is led by a transplant physician or clinical coordinator. LDC sessions incorporate formal didactics, active-participant learning, personal stories, moderated group discussions, role-playing, and other skill-building exercises. LDC sessions are as follows: 1) education about ESRD, KT, and LDKT 2) communication skills building 3) Exploring social networks 4) sharing successful donor and recipient stories 5) encouraging candidate self-efficacy. At session 3, the the Facebook app will be incorporated and given to candidates. The Facebook app provides step-by-step instructions for creating a Facebook post that details each waitlist candidate's struggle with ESRD and their need for a live donor. The post is then uploaded to Facebook so it can be shared with the candidate's Facebook social network.

Group III: Facebook AppActive Control1 Intervention

The Facebook app provides step-by-step instructions for creating a Facebook post that details each waitlist candidate's struggle with ESRD and their need for a live donor. The post is then uploaded to Facebook so it can be shared with the candidate's Facebook social network. The Facebook App prompts users with specific questions to create a narrative. Links to supplemental resources are auto-populated into the post to provide anyone that views the post with vetted information about the risks, benefits, and process of live donation. Candidates using the Facebook app attend one focus group session held at the transplant center where they are provided with verbal instructions and visual demonstrations of installation and use of the Facebook app.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Northwestern UniversityOTHER

1,585 Previous Clinical Trials

916,456 Total Patients Enrolled

4 Trials studying Kidney Failure

75 Patients Enrolled for Kidney Failure

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,356 Previous Clinical Trials

4,314,291 Total Patients Enrolled

9 Trials studying Kidney Failure

9,945 Patients Enrolled for Kidney Failure

Johns Hopkins UniversityLead Sponsor

2,256 Previous Clinical Trials

14,819,296 Total Patients Enrolled

1 Trials studying Kidney Failure

20 Patients Enrolled for Kidney Failure

Media Library

Facebook App Clinical Trial Eligibility Overview. Trial Name: NCT03099434 — N/A

Kidney Failure Research Study Groups: Standard of Care, Live Donor Champion + Facebook App, Facebook App

Kidney Failure Clinical Trial 2023: Facebook App Highlights & Side Effects. Trial Name: NCT03099434 — N/A

Facebook App 2023 Treatment Timeline for Medical Study. Trial Name: NCT03099434 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants is this investigation involving?

"Affirmative. As indicated on clinicaltrials.gov, this medical research effort is currently recruiting participants. Having gone live on April 1st 2017 and being last refreshed on the 6th of April 2022, it seeks to enrol a total of 1350 patients from 2 sites."

Answered by AI

Are there still openings in this research endeavor for individuals?

"Yes, the public records on clinicaltrials.gov attest to this trial's recruitment process which began on April 1st 2017 and was most recently updated June 4th 2022. This medical research seeks 1350 participants across two different sites."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media

2017. "Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03099434.

All > Kidney Transplant